Sagent Pharmaceuticals, Inc. Report issue

For profit Phase 2 Phase 4
Founded: Schaumberg IL United States (2007)
Status: Acquired by Nichi-Iko Pharmaceutical Co., Ltd. (2016)

Organization Overview

First Clinical Trial
2015
NCT02449369
First Marketed Drug
2007
propofol (diprivan)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Sagent Pharmaceuticals Inc. | SAGENT PHARMS | SAGENT PHARMS INC | SAGENT STRIDES